New DNA map test for blood disorder goes Head-to-Head with standard tests
NCT ID NCT05434598
Summary
This study is testing a new, more detailed genetic test called ChromoSeq to see if it works as well as the standard genetic tests used for patients with myelodysplastic syndromes (MDS), a type of blood and bone marrow disorder. Researchers will enroll 60 adults with MDS to compare the results of both tests. They also want to see if doctors find the new test's detailed information useful for patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.